KKRC
GRNA

Kohlberg Kravis Roberts & Co’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-51,358
Closed -$508K – 218
2021
Q3 		$508K Buy
51,358
+9,182
+22% +$90K ﹤0.01% 130
2021
Q2 		$414K Buy
42,176
+22,319
+112% +$218K ﹤0.01% 116
2021
Q1 		$192K Buy
+19,857
New +$195K ﹤0.01% 94

Other funds holding GRNA

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's GRNA Position: Q4 2021 in Review

Kohlberg Kravis Roberts & Co sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q4 2021, closing a stake of 51,358 shares — an estimated $508K sold.

Kohlberg Kravis Roberts & Co first reported a position in GRNA in Q1 2021 and held it in 3 quarters. The position peaked at $508K in Q3 2021. 68 funds tracked by Wall St. Rank hold GRNA as of Q4 2021.

  • Kohlberg Kravis Roberts & Co reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q4 2021 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 51,358 GreenLight Biosciences Holdings, PBC Common Stock shares in Q4 2021, an estimated $508K.
  • Kohlberg Kravis Roberts & Co first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 3 quarters.
  • Kohlberg Kravis Roberts & Co's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $508K in Q3 2021.
  • 68 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q4 2021.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q4 2021, filed 14 Feb 2022.